BTMDW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BCAX, and BFRIW
Should you be buying biote stock or one of its competitors? The main competitors of biote include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Bicara Therapeutics (BCAX), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.
biote (NASDAQ:BTMDW) and 180 Life Sciences (NASDAQ:ATNFW) are both manufacturing companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, risk, community ranking and dividends.
In the previous week, 180 Life Sciences had 2 more articles in the media than biote. MarketBeat recorded 2 mentions for 180 Life Sciences and 0 mentions for biote. 180 Life Sciences' average media sentiment score of 1.44 beat biote's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media.
biote and 180 Life Sciences both received 0 outperform votes by MarketBeat users.
Summary
180 Life Sciences beats biote on 2 of the 3 factors compared between the two stocks.
Get biote News Delivered to You Automatically
Sign up to receive the latest news and ratings for BTMDW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
BTMDW vs. The Competition
Related Companies and Tools
